Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes
Launched by STENO DIABETES CENTER COPENHAGEN · Dec 2, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to detect early signs of long-term complications in children and teenagers with type 1 diabetes (T1D). Researchers want to understand the relationship between factors like blood sugar control, nerve function, and arterial stiffness, which can indicate potential health issues later on. The goal is to improve the health and quality of life for kids with T1D by finding ways to better monitor and manage their condition early on.
To participate, children aged 6 to 18 who have had T1D for more than a year can join the study. They will be followed at the Pediatric Diabetes outpatient clinic in Copenhagen, and their guardians must give consent. Participants will undergo various tests, including blood tests and physical examinations, and they will be invited to return for check-ups every five years over the next two decades. This study aims to gather important information that may help identify those who need extra care to prevent serious complications from diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • T1D\>12 months
- • 6-18 years old prior to inclusion
- • Followed at the Pediatric Diabetes outpatient clinic at Steno Diabetes Center Copenhagen
- • Speaks and reads Danish well enough to understanding the given oral and written information.
- • There is a written consent from the guardianship holder/holders for the child.
- Exclusion Criteria:
- • T1D \< 12 months
- • Known cardiovascular disease
- • Antihypertensive treatment
About Steno Diabetes Center Copenhagen
Steno Diabetes Center Copenhagen is a leading clinical research facility dedicated to advancing the understanding and treatment of diabetes and its complications. As a prominent sponsor of clinical trials, the center focuses on innovative research that bridges clinical practice and scientific inquiry, fostering collaborations with healthcare professionals, researchers, and patients. Committed to improving patient outcomes, Steno Diabetes Center Copenhagen emphasizes evidence-based approaches and cutting-edge methodologies to enhance diabetes management and care, ultimately contributing to the global fight against this chronic disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Herlev, , Denmark
Patients applied
Trial Officials
jesper johannesen
Principal Investigator
Steno Diabetes Center Copenhagen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials